-
Bristol-Myers Squibb, WuXi to open testing facility
SHANGHAI — Drug maker Bristol-Myers Squibb is opening a new testing facility in China under collaboration with a local company there, Bristol said Monday.
WuXi PharmaTech will build, equip and operate the 25,000-sq.-ft. lab in Shanghai to store and test stability samples and perform other services for Bristol.
-
Keryx to present phase-3 clinical data for Zerenex at conference
NEW YORK — Late-stage clinical trial data for a Keryx Biopharmaceuticals drug to treat kidney disease will be presented at a medical conference in Las Vegas.
Keryx said Monday that phase-3 data for the drug Zerenex (ferric citrate), a drug for abnormally high phosphate levels in patients with end-stage kidney disease on dialysis, will be presented at the upcoming National Kidney Foundation spring clinical meetings in April.
The company announced “positive” results from a phase-3 trial of the drug in November.